FAR EAST MEDICAL VIETNAM LIMITED
ActiveFAR EAST MEDICAL VIETNAM LIMITED
ActiveFAR EAST MEDICAL VIETNAM LIMITED
ActiveSummary
Far East Medical Vietnam Limited is one of the most recognized foreign owned healthcare operators in Vietnam, providing high end medical services under the FV Hospital brand. As a long standing international hospital in Ho Chi Minh City, Far East Medical Vietnam Limited has built a strong reputation for clinical quality, modern infrastructure, and a service model aligned with global healthcare standards. With consistent expansion over more than seventeen years, Far East Medical Vietnam Limited remains a central institution in the country’s premium private healthcare market.
Leadership and Shareholders
The company is led by General Director Jean Marcel Guillon, whose long tenure and deep experience continue to shape the hospital’s strategic direction and clinical management. His leadership is supported by an experienced medical and administrative team operating across District 7 and additional offices and clinics in Ho Chi Minh City and Cambodia. Ownership is fully concentrated in Far East Medical HK Limited of Hong Kong, which holds one hundred percent of the equity as shown on page two of the report. This single shareholder structure provides capital stability and allows the company to align investment decisions closely with the expectations of its international parent.
Financial Performance and Operating Conditions
The financial data in the report shows a year of significant expansion in 2023. Total assets nearly doubled compared with the previous year, indicating major investment in facilities, medical equipment, or expansion projects. Sales continued to grow, albeit modestly, supported by rising patient volume and continued demand for high quality healthcare services. Profit moderated compared with the strong levels of 2022 but remained solid for a hospital of this scale. Working capital decreased sharply, which suggests higher short term commitments linked to investment cycles. These patterns reflect a hospital balancing rapid development with the financial demands that accompany large scale healthcare operations.
Business Position and Healthcare Market Outlook
Far East Medical Vietnam Limited holds a distinctive position in Vietnam’s rapidly growing private healthcare sector. Operating within the Phu My Hung urban area, the hospital benefits from a large and affluent patient base, strong international community presence, and proximity to numerous corporate clients. Vietnam’s rising healthcare spending, expanding insurance participation, and increasing demand for specialized treatment continue to support the company’s long term outlook. Its multidisciplinary hospital model, chain of clinics, and broad service offerings place the institution among the most comprehensive private healthcare providers in the country. Future performance will depend on its ability to manage capacity growth, maintain international service standards, and respond to evolving patient expectations in premium care.
VNBIS Support and Business Services
Vanguard Business Information LLC offers detailed financial, operational, and risk assessment services for organizations evaluating Far East Medical Vietnam Limited. The VNBIS Company Comprehensive Report provides a full breakdown of financial performance, liquidity pressures, ownership verification, compliance status, and risk indicators that extend far beyond the executive summary. For investors, lenders, and corporate partners seeking a complete understanding of the hospital’s stability, governance, and long term sustainability, the full report available at www.vnbis.com delivers essential insights for informed decision making.
Legal Profile
Contacts
+ JEAN-MARCEL G
+ TRAN L.Q
Business Sector
Industry Sales Growth
8.62%
12.17%
Companies by industry
2,097
0.0721%
Key Industry Players
Payment History
Financial Performance
| Assets | 0.82% |
| Owner’s Equity | 16.08% |
| Working Capital | 66.74% |
| Net Worth | -64.99% |
| Sales | -77.42% |
| Operating income | -83.32% |
| EBIT | 17.07% |
| Gross Profit Margin | -34.53% |
| Debt to EBITDA | -51.32% |